相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion
Karim Sacre et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States
Irene B. Murimi-Worstell et al.
JOURNAL OF RHEUMATOLOGY (2021)
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)
Julie Chezel et al.
RHEUMATOLOGY (2021)
Systemic lupus erythematosus: The search for the ideal biomarker
Luis Alonso Gonzalez et al.
LUPUS (2021)
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups
Yong-Fei Wang et al.
NATURE COMMUNICATIONS (2021)
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Mineto Ota et al.
CELL (2021)
Elevated Blood and Urinary ICAM-1 is a Biomarker for Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Run-Nan Guo Liu et al.
IMMUNOLOGICAL INVESTIGATIONS (2020)
High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy
Sang Yeop Kim et al.
ARTHRITIS & RHEUMATOLOGY (2020)
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment
Christina Adamichou et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
Sarah Reid et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus
May Y. Choi et al.
AUTOIMMUNITY REVIEWS (2020)
Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease
M. Frodlund et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Evolving story of autoantibodies in systemic lupus erythematosus
David S. Pisetsky
JOURNAL OF AUTOIMMUNITY (2020)
Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort
D. Nikolopoulos et al.
LUPUS (2020)
Identification of Regulatory Modules That Stratify Lupus Disease Mechanism through Integrating Multi-Omics Data
Ting-You Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis
Martina Bertolo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Systemic Lupus Erythematosus
Marianthi Kiriakidou et al.
ANNALS OF INTERNAL MEDICINE (2020)
Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis
Kamala Vanarsa et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Mapping systemic lupus erythematosus heterogeneity at the single-cell level
Djamel Nehar-Belaid et al.
NATURE IMMUNOLOGY (2020)
Biomarker development for axial spondyloarthritis
Matthew A. Brown et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
David S. Pisetsky et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study
Ren Yan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Urinary biomarkers in lupus nephritis
Cristian C. Aragon et al.
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2020)
Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus
Patricia Lopez et al.
RHEUMATOLOGY (2020)
Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis
Orthodoxia Nicolaou et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective
Jan Damoiseaux et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Association between the ratio of aryl hydrocarbon receptor (AhR) in Th17 cells to AhR in Treg cells and SLE skin lesions
Haitao Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways
Evan Der et al.
NATURE IMMUNOLOGY (2019)
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort
May Y. Choi et al.
ARTHRITIS CARE & RESEARCH (2019)
The immune cell landscape in kidneys of patients with lupus nephritis
Arnon Arazi et al.
NATURE IMMUNOLOGY (2019)
Epigenetic programming underpins B cell dysfunction in human SLE
Christopher D. Scharer et al.
NATURE IMMUNOLOGY (2019)
'-Omics' shed light on B cells in lupus
Alessandra B. Pernis et al.
NATURE IMMUNOLOGY (2019)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer et al.
ARTHRITIS & RHEUMATOLOGY (2019)
ANA as an entry criterion for the classification of SLE
David S. Pisetsky et al.
AUTOIMMUNITY REVIEWS (2019)
Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays
Samantha Stanley et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Immunological biomarkers in severe asthma
Dharani Narendra et al.
SEMINARS IN IMMUNOLOGY (2019)
The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity
Allison C. Billi et al.
JCI INSIGHT (2019)
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE
David S. Pisetsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus
Oh Chan Kwon et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus
Lea Winau et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Immunological biomarkers for the development and progression of type 1 diabetes
Chantal Mathieu et al.
DIABETOLOGIA (2018)
Precision medicine in lupus nephritis: can biomarkers get us there?
Dawn J. Caster et al.
TRANSLATIONAL RESEARCH (2018)
Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE
Joan T. Merrill et al.
LUPUS SCIENCE & MEDICINE (2018)
Omics studies: their use in diagnosis and reclassification of SLE and other systemic autoimmune diseases
Maria Teruel et al.
RHEUMATOLOGY (2017)
Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis
Noemie Jourde-Chiche et al.
RHEUMATOLOGY (2017)
The complement system as a potential therapeutic target in rheumatic disease
Leendert A. Trouw et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Antinuclear antibody testing - misunderstood or misbegotten?
David S. Pisetsky
NATURE REVIEWS RHEUMATOLOGY (2017)
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease: reply
Karina de Leeuw et al.
RHEUMATOLOGY (2017)
The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies
Frances Rees et al.
RHEUMATOLOGY (2017)
Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus
Helena M. Kok et al.
RHEUMATOLOGY (2017)
Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus
Patricia Lopez et al.
THROMBOSIS AND HAEMOSTASIS (2017)
NEW PERSPECTIVES IN RHEUMATOLOGY Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA
David S. Pisetsky et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece
Irini Gergianaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Emerging technologies in autoantibody testing for rheumatic diseases
Nancy J. Olsen et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Anti-DNA antibodies - quintessential biomarkers of SLE
David S. Pisetsky
NATURE REVIEWS RHEUMATOLOGY (2016)
IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus
Ming Zhao et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus
Roger C. Ho et al.
AUTOIMMUNITY REVIEWS (2016)
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Romain Banchereau et al.
CELL (2016)
Advances in the diagnosis and classification of systemic lupus erythematosus
Maddalena Larosa et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Anti-Sm is associated with the early poor outcome of lupus nephritis
Sung Soo Ahn et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Toward new criteria for systemic lupus erythematosusa standpoint
M. Aringer et al.
LUPUS (2016)
Clinical and financial burden of active lupus in Greece: a nationwide study
G. Bertsias et al.
LUPUS (2016)
Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?
A. Dima et al.
LUPUS (2016)
Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE
Vinicius Domingues et al.
LUPUS SCIENCE & MEDICINE (2016)
Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus
Hejun Li et al.
CLINICAL RHEUMATOLOGY (2015)
Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus
Amanda J. Steiman et al.
JOURNAL OF RHEUMATOLOGY (2015)
Spot urine protein/creatinine ratio is unreliable estimate of 24h proteinuria in lupus nephritis when the histological scores of activity index are higher
Q. Zhang et al.
LUPUS (2015)
Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Real-Life Scenario
Luis M. Amezcua-Guerra et al.
ARTHRITIS CARE & RESEARCH (2015)
Anti-C1q antibodies in systemic lupus erythematosus
A-M Orbai et al.
LUPUS (2015)
Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus
Jun Ishizaki et al.
RHEUMATOLOGY (2015)
Annual direct medical cost of active systemic lupus erythematosus in five European countries
Andrea Doria et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The complement system in systemic lupus erythematosus: an update
Jonatan Leffler et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Lupus Nephritis Susceptibility Loci in Women with Systemic Lupus Erythematosus
Sharon A. Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE
S. Skeoch et al.
LUPUS (2014)
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Helene Jeltsch-David et al.
NATURE REVIEWS NEUROLOGY (2014)
Autoantibodies and SLE-the threshold for disease
Nancy J. Olsen et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
The Kidney Biopsy in Lupus Nephritis: Is It Still Relevant?
Brad H. Rovin et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus
Shunsei Hirohata et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Direct and Indirect Pathogenic Roles of Autoantibodies in Systemic Autoimmune Diseases
Takao Fujii
ALLERGOLOGY INTERNATIONAL (2014)
Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
Michelle A. Petri et al.
ARTHRITIS AND RHEUMATISM (2013)
Lupus Nephritis: Is the Kidney Biopsy Currently Necessary in the Management of Lupus Nephritis?
Giovanna Giannico et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis
V. Oke et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity
G. Stojan et al.
LUPUS (2013)
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future
Chau-Ching Liu et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2013)
Random spot urine protein/creatinine ratio: a reliable method for monitoring lupus nephritis?
Maria Guedes Marques et al.
CLINICAL KIDNEY JOURNAL (2013)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis
Nicola Bizzaro et al.
AUTOIMMUNITY REVIEWS (2012)
Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis
Hwee Siew Howe et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)
Asthma outcomes: Biomarkers
Stanley J. Szefler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Molecular basis of hereditary C1q deficiency-revisited: identification of several novel disease-causing mutations
L. Schejbel et al.
GENES AND IMMUNITY (2011)
Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares
A. Matrat et al.
LUPUS (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
ANA screening: an old test with new recommendations
Pier Luigi Meroni et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations
George K. Bertsias et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Anti-C1q Autoantibodies in Lupus Nephritis
Renato Alberto Sinico et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis
G. Moroni et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Latest update on the Ro/SS-A autoantibody system
J. Schulte-Pelkum et al.
AUTOIMMUNITY REVIEWS (2009)
The search for lupus biomarkers
Chau-Ching Liu et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)
ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai
Wanling Yang et al.
HUMAN MOLECULAR GENETICS (2009)
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
Noa Schwartz et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus
Yoshiyuki Arinuma et al.
ARTHRITIS AND RHEUMATISM (2008)
Anti-chromatin (anti-nucleosome) antibodies: Diagnostic and clinical value
Jose A. Gomez-Puerta et al.
AUTOIMMUNITY REVIEWS (2008)
Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA): LXI. Value of C-Reactive Protein as a Marker of Disease Activity and Damage
Ana M. Bertoli et al.
JOURNAL OF RHEUMATOLOGY (2008)
Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis
Hilda Fragoso-Loyo et al.
PLOS ONE (2008)
Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus
H. Fragoso-Loyo et al.
ARTHRITIS AND RHEUMATISM (2007)
Biomarkers in systemic lupus erythematosus - 1. General overview of biomarkers and their applicability
GG Illei et al.
ARTHRITIS AND RHEUMATISM (2004)
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-DNA antibody tests
AF Kavanaugh et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
分享论文
